CoChat

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001

Open access
Hartz, Ingeborg, Njølstad, Inger, Eggen, Anne Elise · 2005 · European Heart Journal

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

AIMS: To study the implications of European guidelines on the use of antihypertensives and/or lipid-lowering drugs (LLDs) for primary prevention in a Norwegian population. METHODS AND RESULTS: The Tromsø study is a population-based study in the municipality Tromsø, Norway (from 1974 to till now). This analysis includes 45-79-year-old participants in 2001 (n = 6362, attendance rate 86%). From the age of 60 years in men and 70 years in women, almost all participants were defined as high-risk individuals according to the European guidelines, with established cardiovascular disease, diabetes, or a 10-year risk score of > or =5%. In the primary prevention subgroup of the 45-64-year-olds, recommended antihypertensive and/or LLD use would be higher in men only, 42% compared with 12% on current medication. Among the 65-79-year-olds, >90% would be eligible for antihypertensives and/or LLDs in both sexes when compared with current treatment rates of <30%. In total, 40% of all participants aged 45-79 would be candidates for primary prevention, compared with 15% on current medication. CONCLUSION: The implementation of the European guidelines could imply a doubling of the numbers of Norwegian adults on cardiovascular medication for primary prevention. Contributors to the increase would be more frequent drug use in men and elderly people, particularly for LLD use.

Overview

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehi556

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 3

  1. Wilsgaard T. Longitudinal analysis of cardiovascular risk factors. Thesis, University of Tromsø, Tromsø, Norway, 2002.
  2. Furu K, Skurtveit S, Rosvold EO. Drug use question in Norwegian health surveys–response rate and agreement between specific and open-ended questions. Norw J Epidemiol2003;13:147–154.
  3. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European Cardiovascular Disease Statistics. London: Joint publication by the British Heart Foundation, European Heart Network and the Health Economics Research Centre at the University of Oxford; 2005. http://heartstats.org./uploads/documents%5CPDF.pdf (26 June 2005).

Cited by

See all 64

Metadata

Authors
Hartz, I., Njølstad, I., & Eggen, A. E.
Affiliations
UiT The Arctic University of Norway (NO)
Corresponding author
Hartz, Ingeborg
Venue
European Heart Journal
Published
2005-10-04
Volume
26
Issue
24
Pages
2673-2680
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2157715149
Cited by
61
References
15
Citations by year
2022: 2 · 2017: 1 · 2016: 5 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 11
FWCI
8.70
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Universitetet i Tromsø
  • Høgskolen i Hedmark
  • Norwegian Institute of Public Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
SCORE risk model, primary prevention, cardiovascular drug use, antihypertensive drugs, lipid-lowering drugs, guideline implementation, cardiovascular risk, sex differences, older adults, Tromsø Study
MeSH terms
Aged, Antihypertensive Agents, Hypolipidemic Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Norway, Risk Factors, Incidence, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. https://app.cochat.ai/papers/10.1093/eurheartj/ehi556
The paper
Hartz, I., Njølstad, I., & Eggen, A. E. (2005). Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. European Heart Journal. https://doi.org/10.1093/eurheartj/ehi556

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.